Pacific Biosciences of California PACB Total Cost of Revenue
Discontinued — last reported Q1 '26
Total Cost of Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's total cost of revenue?
- Pacific Biosciences of California (PACB) reported total cost of revenue of $24.34M in Q1 2026.
- How has Pacific Biosciences of California's total cost of revenue changed year-over-year?
- Pacific Biosciences of California's total cost of revenue decreased by 36.8% year-over-year, from $38.52M to $24.34M.
- What is the long-term trend for Pacific Biosciences of California's total cost of revenue?
- Over 4 years (2021 to 2025), Pacific Biosciences of California's total cost of revenue has grown at a 15.3% compound annual growth rate (CAGR), from $64.7M to $114.23M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.